A Phase 1 Trial to Investigate the Biological Equivalence of 5 × 10 mg Tablets and 2 × 25 mg Tablets of Daridorexant in Healthy Male and Female Japanese Participants
Clinical trial NCT05877222 · COMPLETED
Trial details
- NCT number
- NCT05877222
- Sponsor
- Idorsia Pharmaceuticals Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-23
- Primary completion
- 2023-08-04
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.